Qualification
We identify the project, parties, target market, evidence already available, and the decision that needs to be made.
Five controlled stages
Decisions before activity. Evidence before completion.
The process creates a shared view of what is known, what is missing, who owns each responsibility, and what must be true before the project advances.
01 / 05
A project can pause or stop at any gate when evidence or economics do not support the next stage.
Feasibility & route memo
A paid, bounded assessment maps the route, missing evidence, professional providers, decision gates, budget ranges, and timing assumptions.
Setup & coordination
Once the route is accepted, we coordinate company formation and EIN, bank-account application, qualified FDA U.S.-agent sourcing, import operations, and marketplace workstreams under separate scopes.
Launch or close
Evidence is reconciled before a launch, shipment, account transition, or transaction milestone is treated as complete.
Optional support
Post-launch support is offered only with clear responsibilities, response times, and out-of-scope boundaries.
- What exact product, transaction, company, or account is in scope?
- Which facts have been verified, and which are still assumptions?
- Does the client need a new company, EIN route, bank application, or Amazon seller account?
- Who will serve separately as FDA U.S. agent, initial importer, 3PL, and complaint/MDR owner?
- Which third parties must be engaged directly by the client?
- What are the blockers, budget ranges, sequencing constraints, and decision gates?
- Is the recommendation go, conditional go, or no-go?